Crossmark

Linear and dendrimeric antiviral peptides: design, chemical synthesis and activity against human respiratory syncytial virus

Crossref DOI link: https://doi.org/10.1039/C9TB02485A

Published Online: 2020

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Kozhikhova, Ksenia V. https://orcid.org/0000-0001-5124-6826
Shilovskiy, Igor P.

Shatilov, Artem A. https://orcid.org/0000-0002-4675-8074
Timofeeva, Anastasiia V. https://orcid.org/0000-0003-3780-2878
Turetskiy, Evgeny A.

Vishniakova, Liudmila I.

Nikolskii, Aleksandr A. https://orcid.org/0000-0002-4169-0760
Barvinskaya, Ekaterina D.

Karthikeyan, Subramani https://orcid.org/0000-0003-2157-7864
Smirnov, Valeriy V. https://orcid.org/0000-0002-8232-6682
Kudlay, Dmitriy A. https://orcid.org/0000-0003-1878-4467
Andreev, Sergey M. https://orcid.org/0000-0001-8297-579X
Khaitov, Musa R.
Funding

Funding for this research was provided by:

Russian Science Foundation (18-74-10002)
License Information

Accepted Manuscript valid from 2021-03-03
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Ksenia V. Kozhikhova (ORCID)

: Ksenia V. Kozhikhova (ResearcherID)

: Igor P. Shilovskiy (ResearcherID)

: Artem A. Shatilov (ORCID)

: Anastasiia V. Timofeeva (ORCID)

: Aleksandr A. Nikolskii (ORCID)

: Subramani Karthikeyan (ORCID)

: Subramani Karthikeyan (ResearcherID)

: Valeriy V. Smirnov (ORCID)

: Dmitriy A. Kudlay (ORCID)

: Sergey M. Andreev (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 5 November 2019; Accepted 18 February 2020; Advance Article published 3 March 2020; Version of Record published 1 April 2020